Clinical Trial Update: A Study Evaluating the Efficacy and Safety of Bevacizumab in Combination With Chemotherapy in Untreated Metastatic Breast Cancer (RIBBON 1) [Phase 3]

View source ↗

Summary

This update reports results from the Phase 3 RIBBON 1 trial evaluating bevacizumab in combination with chemotherapy for untreated metastatic breast cancer, with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Avastin (bevacizumab)

Snippet

Sponsor: Genentech, Inc. | Conditions: Metastatic Breast Cancer | Phase 3 | Status: UNKNOWN | Results posted: 2013-10-25